• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激素难治性前列腺癌伴骨转移男性患者的症状体验。

Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases.

作者信息

Lindqvist Olav, Rasmussen Birgit H, Widmark Anders

机构信息

Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.

出版信息

Eur J Oncol Nurs. 2008 Sep;12(4):283-90. doi: 10.1016/j.ejon.2008.03.003. Epub 2008 Apr 28.

DOI:10.1016/j.ejon.2008.03.003
PMID:18440862
Abstract

Advanced prostate cancer with skeletal metastases entails significant symptoms from both treatment and the disease itself. Although the diagnosis is a common one, knowledge of the symptom experience late in the disease trajectory is limited. The aim of the present study was to describe the experience of physical symptoms in men with hormone refractory prostate cancer and skeletal metastases. Twenty men answered a quality of life questionnaire before participating in semi-structured interviews. The interviews were analyzed using qualitative description. Findings show that the dominant symptoms were lack of energy and pain. Interestingly when talking about lacking energy the men described three different variants; lack of mental energy or initiative, lack of strength and stamina, and tiredness or sleepiness. Also, three different types of pain were described; pain from skeletal metastases, a diffuse moving pain, and pain not directly caused by the prostate cancer. Though a majority of the men scored being dissatisfied with their sex life; in the interviews, this was not described as a major distress. The findings also showed that the men experienced different symptoms despite the same diagnosis, skeletal metastases, stage, and androgen deprivation treatment, and that these symptoms are not necessarily experienced as problems or causing distress.

摘要

伴有骨转移的晚期前列腺癌会因治疗和疾病本身而引发严重症状。尽管这一诊断很常见,但对于疾病进展后期症状体验的了解却很有限。本研究的目的是描述激素难治性前列腺癌和骨转移男性患者的身体症状体验。20名男性在参加半结构化访谈前回答了一份生活质量问卷。访谈采用定性描述法进行分析。研究结果表明,主要症状是精力不足和疼痛。有趣的是,在谈到精力不足时,男性描述了三种不同的情况:缺乏精神活力或主动性、缺乏力量和耐力、疲倦或困倦。此外,还描述了三种不同类型的疼痛:骨转移引起的疼痛、弥漫性游走性疼痛以及并非由前列腺癌直接导致的疼痛。尽管大多数男性对自己的性生活不满意,但在访谈中,这并未被描述为主要困扰。研究结果还表明,尽管诊断相同、均有骨转移、处于相同阶段且接受雄激素剥夺治疗,但这些男性仍经历了不同的症状,而且这些症状不一定被视为问题或造成困扰。

相似文献

1
Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases.激素难治性前列腺癌伴骨转移男性患者的症状体验。
Eur J Oncol Nurs. 2008 Sep;12(4):283-90. doi: 10.1016/j.ejon.2008.03.003. Epub 2008 Apr 28.
2
Management of the spectrum of hormone refractory prostate cancer.激素难治性前列腺癌谱系的管理
Eur Urol. 2006 Sep;50(3):428-38; discussion 438-9. doi: 10.1016/j.eururo.2006.05.017. Epub 2006 Jun 2.
3
Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease.激素难治性前列腺癌伴骨转移患者骨骼并发症的预测因素。
Br J Cancer. 2005 Sep 19;93(6):633-8. doi: 10.1038/sj.bjc.6602767.
4
Time and bodily changes in advanced prostate cancer: talk about time as death approaches.晚期前列腺癌中的时间与身体变化:谈谈死亡临近时的时间。
J Pain Symptom Manage. 2008 Dec;36(6):648-56. doi: 10.1016/j.jpainsymman.2007.12.013. Epub 2008 May 27.
5
Prostate cancer in the late 1990s: hormone refractory disease options.
Urol Nurs. 1999 Jun;19(2):125-31; quiz 132-3.
6
Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.前列腺癌根治术或密切观察等待术后的时间、症状负担、雄激素剥夺及自我评估的生活质量:斯堪的纳维亚前列腺癌随机研究组4号(SPCG - 4)临床试验
Eur Urol. 2009 Feb;55(2):422-30. doi: 10.1016/j.eururo.2008.08.054. Epub 2008 Sep 2.
7
Men's experience of their life situation when diagnosed with advanced prostate cancer.男性被诊断为晚期前列腺癌时对其生活状况的体验。
Eur J Oncol Nurs. 2009 Sep;13(4):268-73. doi: 10.1016/j.ejon.2009.02.006. Epub 2009 Jun 16.
8
Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.特异性内皮素-A受体拮抗剂ZD4054在无痛或症状轻微的激素抵抗性前列腺癌和骨转移患者中的安全性和有效性:一项双盲、安慰剂对照、随机2期试验。
Eur Urol. 2009 May;55(5):1112-23. doi: 10.1016/j.eururo.2008.11.002. Epub 2008 Nov 29.
9
Quality of life for members of Swedish Prostate Cancer Patient Associations.
Cancer Nurs. 2008 Jan-Feb;31(1):23-31. doi: 10.1097/01.NCC.0000305671.60469.c9.
10
The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer.阿霉素和表阿霉素在转移性激素难治性前列腺癌患者治疗中的作用。
Cancer Treat Rev. 2008 Dec;34(8):710-8. doi: 10.1016/j.ctrv.2008.05.004. Epub 2008 Jul 11.

引用本文的文献

1
Men's experiences of decision-making in life-prolonging treatments of metastatic castration-resistant prostate cancer - wishing for a process adapted to personal preferences: a prospective interview study.转移性去势抵抗性前列腺癌延长生命治疗中男性的决策经历——期望有一个适应个人偏好的过程:一项前瞻性访谈研究
BMC Med Inform Decis Mak. 2025 Mar 31;25(1):153. doi: 10.1186/s12911-025-02985-x.
2
Symptoms and quality of life among men starting treatment for metastatic castration-resistant prostate cancer - a prospective multicenter study.开始转移性去势抵抗性前列腺癌治疗的男性的症状和生活质量-一项前瞻性多中心研究。
BMC Palliat Care. 2024 Mar 27;23(1):80. doi: 10.1186/s12904-024-01410-w.
3
Quality of life issues in patients with bone metastases: A systematic review.
骨转移患者的生活质量问题:一项系统综述。
Support Care Cancer. 2023 Dec 13;32(1):18. doi: 10.1007/s00520-023-08241-0.
4
Strategies for living well with hormone-responsive advanced prostate cancer-a qualitative exploration.激素反应性晚期前列腺癌的生活策略:一项定性探索。
Support Care Cancer. 2021 Mar;29(3):1317-1325. doi: 10.1007/s00520-020-05594-8. Epub 2020 Jul 6.
5
Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T.拼拼凑凑:为 sipuleucel-T 完成作用机制拼图。
J Natl Cancer Inst. 2020 Jun 1;112(6):562-573. doi: 10.1093/jnci/djaa021.
6
PREVALENCE OF FATIGUE AND IMPACT ON QUALITY OF LIFE IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS: the VITAL study.雄激素剥夺治疗抵抗性前列腺癌患者的疲劳发生率及其对生活质量的影响:VITAL 研究。
BMC Urol. 2019 Oct 16;19(1):92. doi: 10.1186/s12894-019-0527-8.
7
Quality of life in men with metastatic prostate cancer in their final years before death - a retrospective analysis of prospective data.在死亡前最后几年患有转移性前列腺癌的男性的生活质量 - 前瞻性数据的回顾性分析。
BMC Palliat Care. 2018 Dec 3;17(1):126. doi: 10.1186/s12904-018-0381-6.
8
Is the fatigue an adverse event of the second generation of hormonal therapy? Data from a literature-based meta-analysis.第二代激素治疗的不良反应是否为疲劳?基于文献的荟萃分析数据。
Med Oncol. 2018 Jan 31;35(3):29. doi: 10.1007/s12032-018-1081-z.
9
Qualitative research into the symptom experiences of adult cancer patients after treatments: a systematic review and meta-synthesis.成人癌症患者治疗后症状体验的定性研究:系统评价和元综合。
Support Care Cancer. 2013 Jan;21(1):9-25. doi: 10.1007/s00520-012-1573-x. Epub 2012 Sep 13.
10
Pain in castration-resistant prostate cancer with bone metastases: a qualitative study.去势抵抗性前列腺癌伴骨转移的疼痛:一项定性研究。
Health Qual Life Outcomes. 2011 Oct 12;9:88. doi: 10.1186/1477-7525-9-88.